London Investor Evening

RNS Number : 9140E

Immupharma PLC

15 February 2018

 

	15 February 2018

ImmuPharma PLC

("ImmuPharma" or the "Company")

London Investor Evening

Monday 26 February 2018 @ 6pm

ImmuPharma PLC (LSE: IMM), specialist drug discovery and development company, is pleased to announce that Tim McCarthy, Chairman, will be presenting at an investor evening hosted by Turner Pope Investments (TPI) Ltd. TPI acted as agent in the recent £10 million fundraise by ImmuPharma.

The event will be held on Monday 26^th February 2018 in London, EC2 and will commence at 6pm. Further details on the event will be provided upon registration. To Register your interest, please email [e-mail] and [e-mail] or call 0203 621 4120.

-Ends-

For further information please contact: ImmuPharma plc (www.immupharma.org) + 44 (0) 20 7152 4080 Tim McCarthy, Chairman Lisa Baderoon, Head of Investor Relations [e-mail] Twitter: @immupharma + 44 (0) 7721 413496 Northland Capital Partners Limited (NOMAD & Broker) David Hignell, Jamie Spotswood, Corporate Finance Rob Rees, Corporate Broking [phone]

 

END

 

 

NRAMMGMZKDLGRZM